12/21/2015 Tracks, Regulators Aim for Improved Testing | BloodHorse.com

http://www.bloodhorse.com/horse­racing/articles/96597/tracks­regulators­aim­for­improved­testing/print 1/2

Tracks, Regulators Aim for Improved Testingby Frank Angst Date Posted: 12/16/2015 5:21:36 PM

In a story that stunned attendees at the Global Symposium on Racing and Gaming Dec. 8, Kentucky Horse RacingCommission equine medical director Mary Scollay told a story of a misunderstanding between a lab and stateregulator that compromised drug testing in a state (not Kentucky).

"The contract required a three­day turnaround time of samples but the lab director interpreted that to mean if workwasn't completed by the end of three days, he would report the samples as passed. And he did," Scollay said. "Iassure that is not what the commission intended when they wrote their contract."

The anecdote served as a reminder of the importance to make sure contracts properly outline the work and level ofwork state regulators require from their contracted testing lab. It's become a point of emphasis in the industry.

NTRA Safety and Integrity Alliance executive director Steve Koch said his group's current code of standardsrequiring regulators send samples to labs accredited by the Racing Medication and Testing Consortium has beenupdated to call on regulators to also make sure testing contracts call for the proper level of examination.

Koch said the 23 alliance racetracks, which account for 90% of graded stakes in the U.S., will be asked to work withtheir state regulators to make sure testing programs are at the proper standard. Those standards include reliance onLC­MS instruments in testing and ending any pooling of samples.

"So the point of putting this into the code of standards is so that the racetracks start asking those questions, getengaged; and hopefully the regulators will engage back," Koch said. "That way everybody can be very comfortable.We're all paying into this. Ultimately it's coming out of horse racing to pay for these things, one way or another,whether it's directly from the track, through levies, or whatever it might be.

"The point of this is to actually drive that engagement across the industry. It's everyone—the horsemen, theracetrack operators, and the regulators should be involved in this process."

Scollay noted that quality testing strengthens the racing product.

"A racetrack operator should be aware that poor drug testing impacts the quality and credibility of the product you'repromoting," Scollay said. "Bad drug testing is going to cost you money at the bottom­line level."

RMTC executive director Dionne Benson noted that the group has prepared a document to help states make surethey call for a proper level of testing when they formulate contracts with labs. Benson said in the nine months thedocument has been in place, several states have already used it to install new agreements on testing.

Benson noted the document was produced after the RMTC examined contracts provided by several states with theirtesting labs. That examination certainly revealed a need.

"What we did was review a number of commission contracts. A number of jurisdictions provided them and we wereable to review. Some of the information was very interesting; there are a number of jurisdictions that are doing greatwork. By contrast there are some jurisdictions that don't even have a written contract," Benson said. "I'm not surehow you would specify what the requirements are if you're not writing something down. ... There was variation intesting, preparation of samples, and cost of testing."

Use of accredited labs by all racing jurisdictions is one of the pillars of the National Uniform Medication Program,which aims to bring uniformity to medication rules, testing and penalties, state by state. Currently 12 of the 14 labsbeing used by racetracks in the U.S. are accredited by the RMTC.

Koch noted that accreditation by the RMTC only means that labs are capable of doing proper testing work. But state

12/21/2015 Tracks, Regulators Aim for Improved Testing | BloodHorse.com

http://www.bloodhorse.com/horse­racing/articles/96597/tracks­regulators­aim­for­improved­testing/print 2/2

contracts have to ensure the proper level of testing is requested of those labs.

"It is your regulator's signed operating agreement with those labs that dictates how the laboratory actually executeson your drug­testing program," Koch said, speaking to racetracks. "Failures we've seen recently sometimes relate tothe pitfalls of these misaligned laboratory service agreements."

Benson said the RMTC's 40­page document on proper request­for­proposals for drug testing agreements with labswill help states ensure their contracts call for the proper level of testing.

"The RMTC board, early on in this exercise, recognized that there was a gap between what the RMTC accreditationstandards required and what was necessarily being required by the jurisdiction contracts," Benson said. "So toensure that we have the laboratories able to perform at a high level, and that they are performing at a high level, wefelt it was necessary to take this next step. The key to this is ensuring that the laboratory contracts with eachcommission effectively require their best testing."

The alliance and the RMTC want racing to move to instrument testing (LC­MS), which is capable of searching for awide spectrum of substances, as opposed to ELISA tests, which provide more specific searches.

The standards also call for a move away from pooling of samples where labs run preliminary tests on severalsamples at one time. If a positive is found, all of the samples are tested further but if no positive is found, all of thesamples are passed. Scollay noted that when such pooling is done, concentration levels of any potential substanceare reduced, making them more difficult to pick up.

Benson acknowledged that some states likely will have to spend more money, although some savings could bereached by testing fewer samples. She said testing fewer samples at a higher level is preferred to testing many at alower level.

"To be frank, this will likely represent an increase in cost for some jurisdictions, especially if you intend to do thesame number of samples," Benson said.

Scollay encouraged regulators and tracks to make sure their lab contract calls for the proper level of testing.

"My take home message is, "Know what you want from your drug­testing program.' If you're unsure what you want,the model RFP is a good place to start because in addition to telling you the things that you should require, itexplains why you should require them so you can have some confidence when you go to your procurement agencysaying, 'We have to do it this way' it's important,'" Scollay said. "Require the service provider to do the work. Makesure your contract doesn't offer the opportunity for somebody to cut a corner."

Copyright © 2015 The Blood­Horse, Inc. All Rights Reserved.

SUBSCRIBE to The Blood­Horse magazine TODAY!